DN Nephrologie-Service GmbH, based in Neunkirchen, acts as a central procurement agency for medical supplies. The company provides specialized services for nephrological facilities. With a lean organizational structure, the company supports its clients' operations through efficient processes. The capital base is solid, with an equity ratio of approximately 84%.
Das Betreiben einer zentralen Medikamentenbeschaffung sowie die Erbringung von Dienstleistungen für nephrologische Einrichtungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Saarbrücken Local Court, HRB 16045 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Markus Eiden | Geschäftsführer(in) | Hermeskeil |
Source: German Commercial Register (Handelsregister) Saarbrücken Local Court, HRB 16045 (as of 30 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 21.01.2016 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 23.07.2015 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 18.02.2014 | Business Address Registered | In der Vogelsbach 1, 66540 Neunkirchen |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 23.07.2015 | Capital Increase | +2.475.000 € | 2.500.000 € |
| 06.11.2006 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Saarbrücken Local Court, HRB 16045 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€3.6M2 | €679,174 | €14,146,013 | 6 |
| 2023 | Rohergebnis€3.8M2 | €945,469 | €14,325,347 | 6 |
| 2022 | Rohergebnis€4.3M2 | €1,201,268 | €13,946,271 | 6 |
| 2021 | Rohergebnis€4.2M2 | €1,243,930 | €13,977,107 | 6 |
| 2020 | Rohergebnis€4.3M2 | €1,298,803 | €14,667,540 | 6 |
| 2019 | -€529,823 | €1,340,274 | €14,735,561 | 6 |
| 2018 | -€761,768 | €1,562,264 | €14,831,666 | 4 |
| 2017 | Rohergebnis€4.8M2 | €1,545,895 | €13,554,699 | 4 |
| 2016 | Rohergebnis€5M2 | €1,568,460 | €16,102,192 | 4 |
| 2015 | Rohergebnis€4.9M2 | €1,534,939 | €14,952,855 | 4 |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Saarbrücken Local Court, HRB 16045 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €2,626,901 | 95.4% |
| Depreciation | €126,345 | 4.6% |
